FDA clears Johnson & Johnson's Ottava robotic surgical system
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
July 22, 2026 7:00 AM EDTBuilt to open new possibilities in surgery, OTTAVA creates a new category in soft tissue robotics
System authorized for use in multiple procedures in general surgery within the upper abdomen
System features are designed to enable surgical teams and hospitals to expand OR capacity, streamline clinical workflows, and elevate surgical performance
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA Robotic Surgical System, the worlds first table-integrated soft... More
